Macrophages during the fibrotic process: M2 as friend and foe

Frontiers in Immunology

Volumn 6, Issue NOV, 2015, Pages

  Braga, Tarcio Teodoro ^a   Agudelo, Juan Sebastian Henao ^b   Camara, Niels Olsen Saraiva ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cell metabolism; Fibrosis; Macrophage activation; Myofibroblasts; Polarization

Indexed keywords

ARGINASE; BONE MORPHOGENETIC PROTEIN; INTERLEUKIN 10; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AEROBIC METABOLISM; ANTIGEN PRESENTATION; CELL PROLIFERATION; DISEASE EXACERBATION; FIBROSIS; GLUCOSE METABOLISM; IMMUNE RESPONSE; LIPID STORAGE; MACROPHAGE; MOUSE; MYOFIBROBLAST; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN EXPRESSION; SCAR FORMATION; SHORT SURVEY; SIGNAL TRANSDUCTION; TISSUE REPAIR; WOUND HEALING;

EID: 84949635133     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00602     Document Type: Short Survey

References (85)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 5(12):953-64. doi: 10.1038/nri1733.
2. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest (2012) 122(3):787-95. doi:10.1172/JCI59643.
3. Duffield JS. Macrophages and immunologic inflammation of the kidney. Semin Nephrol (2010) 30(3):234-54. doi:10.1016/j.semnephrol.2010.03.003.
4. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis (2010) 30(3):245-57. doi:10.1055/s-0030-1255354.
5. Cavaillon JM. The historical milestones in the understanding of leukocyte biology initiated by Elie Metchnikoff. J Leukoc Biol (2011) 90(3):413-24. doi:10.1189/jlb.0211094.
6. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science (2010) 327(5966):656-61. doi:10.1126/science.1178331.
7. Wynn TA, Chawla A. Macrophage biology in development, homeostasis and disease. Nature (2013) 496(7446):445-55. doi:10.1038/nature12034.
8. Dey A, Allen J, Hankey-Giblin PA. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol (2014) 5:683. doi:10.3389/fimmu.2014.00683.
9. Cassado Ados A, D'Império Lima MR, Bortoluci KR. Revisiting mouse peritoneal macrophages: heterogeneity, development, and function. Front Immunol (2015) 6:225. doi:10.3389/fimmu.2015.00225.
10. Lichanska AM, Hume DA. Origins and functions of phagocytes in the embryo. Exp Hematol (2000) 28(6):601-11. doi:10.1016/S0301-472X(00)00157-0.
11. Shepard JL, Zon LI. Developmental derivation of embryonic and adult macrophages. Curr Opin Hematol (2000) 7(1):3-8. doi:10.1097/00062752-200001000-00002.
12. Schulz C, Gomez Perdiguero E. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science (2012) 336(6077):86-90. doi:10.1126/science.1219179.
13. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol (2006) 18(1):39-48. doi:10.1016/j.coi.2005.11.006.
14. Wei S, Nandi S, Chitu V, Yeung YG, Yu W, Huang M, et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J Leukoc Biol (2010) 88(3):495-505. doi:10.1189/jlb.1209822.
15. Gomez Perdiguero E, Klapproth K, Schulz C, Busch K, Azzoni E, Crozet L, et al. Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors. Nature (2015) 518(7540):547-51. doi:10.1038/nature13989.
16. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 19(1):71-82. doi:10.1016/S1074-7613(03)00174-2.
17. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 317(5838):666-70. doi:10.1126/science.1142883.
18. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 27:669-92. doi:10.1146/annurev.immunol.021908.132557.
19. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164(12):6166-73. doi:10.4049/jimmunol.164.12.6166.
20. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8(12):958-69. doi:10.1038/nri2448.
21. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol (2010) 11(10):889-96. doi:10.1038/ni.1937.
22. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol (2004) 25(12):677-86. doi:10.1016/j.it.2004.09.015.
23. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 177(10):7303-11. doi:10.4049/jimmunol.177.10.7303.
24. Pesce J, Kaviratne M, Ramalingam TR, Thompson RW, Urban JF Jr, Cheever AW, et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest (2006) 116(7):2044-55. doi:10.1172/JCI27727.
25. Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol (2009) 183(10):6469-77. doi:10.4049/jimmunol.0901575.
26. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol (2008) 214(2):199-210. doi:10.1002/path.2277.
27. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol (2002) 3(5):349-63. doi:10.1038/nrm809.
28. Friedman SL. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol (2004) 1(2):98-105. doi:10.1038/ncpgasthep0055.
29. Liu JY, Li SR, Ji SX. [Effects of connective tissue growth factor antisense oligonucleotides on the cultured human keloid fibroblasts in vitro]. Zhonghua Zheng Xing Wai Ke Za Zhi (2004) 20(6):454-6.
30. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol (2007) 170(6):1807-16. doi:10.2353/ajpath.2007.070112.
31. Rockey DC, Housset CN, Friedman SL. Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J Clin Invest (1993) 92(4):1795-804. doi:10.1172/JCI116769.
32. Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol (2014) 60(5):1090-6. doi:10.1016/j.jhep.2013.12.025.
33. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell (2001) 12(9):2730-41. doi:10.1091/mbc.12.9.2730.
34. Conway B, Hughes J. Cellular orchestrators of renal fibrosis. QJM (2012) 105(7):611-5. doi:10.1093/qjmed/hcr235.
35. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmoulière A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol (2012) 180(4):1340-55. doi:10.1016/j.ajpath.2012.02.004.
36. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One (2009) 4(10):e7475. doi:10.1371/journal.pone.0007475.
37. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol (2010) 38(7):548-56. doi:10.1016/j.exphem.2010.03.004.
38. Forino M, Torregrossa R, Ceol M. TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture. Int J Exp Pathol (2006) 87(3):197-208. doi:10.1111/j.1365-2613.2006.00479.x.
39. Li J, Bertram JF. Review: endothelial-myofibroblast transition, a new player in diabetic renal fibrosis. Nephrology (Carlton) (2010) 15(5):507-12. doi:10.1111/j.1440-1797.2010.01363.x.
40. Stahl D, Venetz JP, Lacroix-Desmazes S, Rondeau E, Bonnin E, Kazatchkine MD, et al. Idiopathic membranous glomerulonephritis is associated with altered patterns of self-reactive IgM and IgG antibody repertoires. Scand J Immunol (2001) 54(5):534-42. doi:10.1046/j.1365-3083.2001.01000.x.
41. Yang L, Liu X, Fu H, Qiang O, Huang M. [TGF beta 1 and ET-1 expression in the peripheral blood of patients with cirrhosis]. Hua Xi Yi Ke Da Xue Xue Bao (2001) 32(2):202-3.
42. Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Müller GA, et al. Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol (2003) 285(6):F1060-7. doi:10.1152/ajprenal.00191.2002.
43. Rae F, Woods K, Sasmono T, Campanale N, Taylor D, Ovchinnikov DA, et al. Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol (2007) 308(1):232-46. doi:10.1016/j.ydbio.2007.05.027.
44. Eardley KS, Zehnder D, Quinkler M, Lepenies J, Bates RL, Savage CO, et al. The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. Kidney Int (2006) 69(7):1189-97. doi:10.1038/sj.ki.5000212.
45. Lim JH. Radiologic findings of clonorchiasis. AJR Am J Roentgenol (1990) 155(5):1001-8. doi:10.2214/ajr.155.5.2120938.
46. Kitamoto K, Machida Y, Uchida J, Izumi Y, Shiota M, Nakao T, et al. Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci (2009) 111(3):285-92. doi:10.1254/jphs.09227FP.
47. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest (2002) 110(12):1859-68. doi:10.1172/JCI200215045.
48. Koh TJ, DiPietro LA. Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med (2011) 13:e23. doi:10.1017/S1462399411001943.
49. Mahdavian Delavary B, van der Veer WM, van Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology (2011) 216(7):753-62. doi:10.1016/j.imbio.2011.01.001.
50. Lech M, Anders HJ. Macrophages and fibrosis: how resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta (2013) 1832(7):989-97. doi:10.1016/j.bbadis.2012.12.001.
51. Cheng S, Lovett DH. Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol (2003) 162(6):1937-49. doi:10.1016/S0002-9440(10)64327-1.
52. Tan TK, Zheng G, Hsu TT, Lee SR, Zhang J, Zhao Y, et al. Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Lab Invest (2013) 93(4):434-49. doi:10.1038/labinvest.2013.121.
53. Lutz J, Yao Y, Song E, Antus B, Hamar P, Liu S, et al. Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation (2005) 79(6):655-61. doi:10.1097/01.TP.0000151644.85832.B5.
54. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol (2007) 178(8):5288-95. doi:10.4049/jimmunol.178.8.5288.
55. Pellicoro A, Aucott RL, Ramachandran P, Robson AJ, Fallowfield JA, Snowdon VK, et al. Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis. Hepatology (2012) 55(6):1965-75. doi:10.1002/hep.25567.
56. Ramachandran P, Pellicoro A, Vernon MA, Boulter L, Aucott RL, Ali A, et al. Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci U S A (2012) 109(46):E3186-95. doi:10.1073/pnas.1119964109.
57. Pradere JP, Kluwe J, De Minicis S, Jiao JJ, Gwak GY, Dapito DH, et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology (2013) 58(4):1461-73. doi:10.1002/hep.26429.
58. Ricardo SD, van Goor H, Eddy AA. Macrophage diversity in renal injury and repair. J Clin Invest (2008) 118(11):3522-30. doi:10.1172/JCI36150.
59. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 101(4):890-8. doi:10.1172/JCI1112.
60. Vernon MA, Mylonas KJ, Hughes J. Macrophages and renal fibrosis. Semin Nephrol (2010) 30(3):302-17. doi:10.1016/j.semnephrol.2010.03.004.
61. Boisvert R, Boisclair G, Picotte L. [The dental health of institutionalized elderly patients: from awareness to action]. J Can Dent Assoc (1990) 56(3):223-4.
62. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation (2004) 110(19):3121-8. doi:10.1161/01.CIR.0000147181.65298.4D.
63. Clementy N, Piver E. Galectin-3 in patients undergoing ablation of atrial fibrillation. IJC Metabolic & Endocrine (2014) 5(0):56-60. doi:10.1016/j.ijcme.2014.10.003.
64. Braga TT, Correa-Costa M, Guise YF, Castoldi A, de Oliveira CD, Hyane MI, et al. MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating alternative M2 macrophages. Mol Med (2012) 18:1231-9. doi:10.2119/molmed.2012.00131.
65. Cao Q, Wang Y, Harris DC. Macrophage heterogeneity, phenotypes, and roles in renal fibrosis. Kidney Int Suppl (2011) (2014) 4(1):16-9. doi:10.1038/kisup.2014.4.
66. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest (2004) 114(3):438-46. doi:10.1172/JCI200420997.
67. Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl (2011) (2014) 4(1):34-8. doi:10.1038/kisup.2014.7.
68. Cao Q, Harris DC. Macrophages in kidney injury, inflammation, and fibrosis. Physiology (Bethesda) (2015) 30(3):183-94. doi:10.1152/physiol.00046.2014.
69. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med (2012) 18(7):1028-40. doi:10.1038/nm.2807.
70. Lin YH, Chou CH, Wu XM, Chang YY, Hung CS, Chen YH, et al. Aldosterone induced galectin-3 secretion in vitro and in vivo: from cells to humans. PLoS One (2014) 9(9):e95254. doi:10.1371/journal.pone.0085728.
71. Ganeshan K, Chawla A. Metabolic regulation of immune responses. Annu Rev Immunol (2014) 32:609-34. doi:10.1146/annurev-immunol-032713-120236.
72. Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity (2015) 42(3):406-17. doi:10.1016/j.immuni.2015.02.002.
73. Zhu L, Zhao Q, Yang T, Ding W, Zhao Y. Cellular metabolism and macrophage functional polarization. Int Rev Immunol (2015) 34(1):82-100. doi:10.3109/08830185.2014.969421.
74. Kelly B, O'Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res (2015) 25(7):771-84. doi:10.1038/cr.2015.68.
75. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Nature (2013) 496(7444):238-42. doi:10.1038/nature11986.
76. Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity (2015) 42(3):419-30. doi:10.1016/j.immuni.2015.02.005.
77. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab (2006) 4(1):13-24. doi:10.1016/j.cmet.2006.08.006.
78. Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, et al. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun (2013) 4:2834. doi:10.1038/ncomms3834.
79. Pawlus MR, Hu CJ. Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response. Cell Signal (2013) 25(9):1895-903. doi:10.1016/j.cellsig.2013.05.018.
80. Wallace DC. A mitochondrial bioenergetic etiology of disease. J Clin Invest (2013) 123(4):1405-12. doi:10.1172/JCI61398.
81. Wallace DC, Chalkia D. Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol (2013) 5(11):a021220. doi:10.1101/cshperspect.a021220.
82. Kim SJ, Cheresh P, Jablonski RP, Williams DB, Kamp DW. The role of mitochondrial DNA in mediating alveolar epithelial cell apoptosis and pulmonary fibrosis. Int J Mol Sci (2015) 16(9):21486-519. doi:10.3390/ijms161023259.
83. Han SH, Malaga-Dieguez L, Chinga F, Kang HM, Tao J, Reidy K, et al. Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J Am Soc Nephrol (2015). doi:10.1681/ASN.2014121181.
84. Qiu J, Tu Z, Shi Y, Zhang L, Li Q, Wang W, et al. Interference of cyclosporine on glucose metabolism: potential role in chronic transplantation kidney fibrosis. Transplant Proc (2006) 38(7):2065-8. doi:10.1016/j.transproceed.2006.06.047.
85. You M, Jogasuria A, Taylor C, Wu J. Sirtuin 1 signaling and alcoholic fatty liver disease. Hepatobiliary Surg Nutr (2015) 4(2):88-100. doi:10.3978/j.issn.2304-3881.2014.12.06.